We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
1401
Teladoc Health
TDOC
$1.29B
$174K 0.01%
7,346
-96,173
-93% -$2.59M
ZLAB icon
1402
Zai Lab
ZLAB
$2.8B
$174K 0.01%
5,664
+5,035
+800% +$159K
AIRC
1403
DELISTED
Apartment Income REIT Corp.
AIRC
$174K 0.01%
5,078
-3,366
-40% -$123K
DINO icon
1404
HF Sinclair
DINO
$15.2B
$173K 0.01%
3,320
-8,555
-72% -$492K
PLNT icon
1405
Planet Fitness
PLNT
$3.7B
$173K 0.01%
2,198
-1,515
-41% -$106K
REGL icon
1406
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.81B
$172K 0.01%
2,400
-2,286
-49% -$162K
VIOO icon
1407
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.32B
$172K 0.01%
1,980
-952
-32% -$84.5K
VOR icon
1408
Vor Biopharma
VOR
$1.25B
$172K 0.01%
1,294
-1,039
-45% -$103K
BFLY icon
1409
Butterfly Network
BFLY
$2.52B
$171K 0.01%
69,450
+58,984
+564% +$212K
DT icon
1410
Dynatrace
DT
$14.6B
$171K 0.01%
4,446
-9,282
-68% -$337K
DV icon
1411
DoubleVerify
DV
$2.03B
$171K 0.01%
7,792
-12,178
-61% -$317K
ERIC icon
1412
Ericsson
ERIC
$33.1B
$171K 0.01%
29,346
-32,762
-53% -$197K
EVR icon
1413
Evercore
EVR
$11.7B
$171K 0.01%
1,573
-460
-23% -$48K
KRG icon
1414
Kite Realty
KRG
$5.28B
$171K 0.01%
8,129
-13,548
-62% -$276K
OLN icon
1415
Olin
OLN
$2.17B
$171K 0.01%
3,218
-4,250
-57% -$226K
ARMK icon
1416
Aramark
ARMK
$15.8B
$170K 0.01%
5,690
-7,810
-58% -$215K
AZTA icon
1417
Azenta
AZTA
$1.56B
$170K 0.01%
2,913
-6,281
-68% -$321K
DHT icon
1418
DHT Holdings
DHT
$2.88B
$170K 0.01%
19,085
+8,487
+80% +$77.2K
EBS icon
1419
Emergent Biosolutions
EBS
$227M
$170K 0.01%
14,416
+11,716
+434% +$181K
LUNG icon
1420
Pulmonx
LUNG
$99.2M
$170K 0.01%
20,207
+17,929
+787% +$171K
FOXF icon
1421
Fox Factory Holding Corp
FOXF
$904M
$169K 0.01%
1,848
-2,081
-53% -$194K
Z icon
1422
Zillow
Z
$7.59B
$169K 0.01%
5,259
-9,258
-64% -$307K
SYNA icon
1423
Synaptics
SYNA
$4.18B
$168K 0.01%
1,764
-4,988
-74% -$479K
VUZI icon
1424
Vuzix
VUZI
$223M
$168K 0.01%
46,415
+40,842
+733% +$187K
SGI
1425
Somnigroup International
SGI
$14.1B
$168K 0.01%
4,907
-3,811
-44% -$115K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.